Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Other Disease Areas
Filter     Order     Display # 
Date Item Title
01 Jul 2008 FDA Approves EVOLENCE(R), a New Generation Collagen-Based Facial Filler
01 Jul 2008 Proton Pump Inhibitor ACIPHEX(R) 20 mg Receives Approvalfor Short-Term Treatment of GERD in Adolescents in United States
01 Jul 2008 Salix Initiates Phase 3 for Rifaximin in Non–Constipation Irritable Bowel Syndrome
30 Jun 2008 Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal(R) as Compared to Topical Testim(R) Examining Effects on Male Fertility and Testicular Function
30 Jun 2008 Affymax Initiates Clinical Trial of Hematide(TM) to Evaluate Correction of Anemia in Chronic Renal Failure Patients on Dialysis
30 Jun 2008 Indevus Receives Approvable Letter from FDA for NEBIDO(R)
30 Jun 2008 ThromboGenics Announces Positive Results from its Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
25 Jun 2008 SurModics Announces Initiation by Merck & Co., Inc. of Phase IIb Clinical Trial for I-vation(TM) TA
25 Jun 2008 Lux Biosciences Completes Enrollment in LUMINATE Pivotal Trial Program for Novel Uveitis Therapy, LUVENIQ(TM)
24 Jun 2008 Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
24 Jun 2008 Sirion Therapeutics Announces FDA Approval of Durezol(TM) for Treatment of Postoperative Ocular Inflammation and Pain
24 Jun 2008 Warner Chilcott Announces Approval of DORYX Delayed-Release 150 mg Tablets
23 Jun 2008 Tranzyme Pharma Announces Successful Thorough QT/QTc Study of Ghrelin Agonist TZP-101
22 Jun 2008 Aradigm Initiates Phase 2 Study of Inhaled Liposomal Ciprofloxacin in Bronchiectasis
22 Jun 2008 FDA Approves GlaxoSmithKline's AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
19 Jun 2008 Eurand Receives Approvable Letter from FDA for EUR-1008 (Zentase(TM))
18 Jun 2008 AVONTEC announces results of a multiple dose clinical phase I study with its drug candidate AVT-02 UE ointment after topical treatment in male healthy volunteers
18 Jun 2008 Elixir Pharmaceuticals Announces Ghrelin Agonist Data Presentation at the Endocrine Society Annual Meeting
18 Jun 2008 Allergan Receives U.S. Food and Drug Administration Approval for TRIVARIS(TM) (triamcinolone acetonide injectable suspension) 80 mg/mL
18 Jun 2008 SkyePharma Announces Second Flutiform Phase III Efficacy Study Meets Primary Endpoints
18 Jun 2008 Inotek Commences Phase 1 Trial in Glaucoma with Selective Adenosine 1 (A1) Agonist
17 Jun 2008 Tranzyme Pharma's Ghrelin Agonist TZP-102 Demonstrates Safety and High Oral Bioavailability in the Successful Completion of a Phase I Trial
16 Jun 2008 Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
15 Jun 2008 Altus Pharmaceuticals Reports Last Patient Visit Of Trizytek(TM) Phase 3 Efficacy Trial
10 Jun 2008 CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
10 Jun 2008 Allergan Announces Agreement to Acquire Aczone(R) Gel 5%
08 Jun 2008 Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
04 Jun 2008 Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p
04 Jun 2008 Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
04 Jun 2008 Callisto Pharmaceuticals Opens Phase I Clinical Trial of SP-304 to Treat Chronic Constipation and Irritable Bowel Syndrome
04 Jun 2008 Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
04 Jun 2008 Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
03 Jun 2008 Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis
02 Jun 2008 European Union's CHMP Issues Positive Opinion on Sugammadex
30 May 2008 Orion receives rights for incontinence drug Kentera(R) from Recordati
29 May 2008 Repros Therapeutics Inc. Announces That Initial Findings for Proellex(R) Show No Adverse Effects on the Endometrium after One Year on Drug
28 May 2008 Orphan Therapeutics announces initiation of rolling NDA submission for Lucassin(R) (terlipressin) for the treatment of Hepatorenal Syndrome Type 1
28 May 2008 Santarus Announces Development Program for New ZEGERID Prescription Product
28 May 2008 Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing by FDA for the Treatment of Overactive Bladder
23 May 2008 ThromboGenics Presents Further Results of the Vitreomacular Traction Trial (MIVI IIT) at the Euretina Annual Meeting in Vienna
22 May 2008 Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
21 May 2008 Osiris Therapeutics Initiates Phase II Clinical Trial Evaluating Prochymal(TM) for Chronic Obstructive Pulmonary Disease
21 May 2008 Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
21 May 2008 Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
21 May 2008 Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American Urological Association (AUA)
21 May 2008 Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
21 May 2008 Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
21 May 2008 Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week
21 May 2008 Tioga Pharmaceuticals’ Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
20 May 2008 Dynogen presents results of its positive phase 2a IBS-c study with DPP733
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 151 - 200 of 985

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics